Literature DB >> 27622121

Pathological Model of Hemangioma-New Thinking on Hemangioma Classification.

Zundi Xu1.   

Abstract

Entities:  

Year:  2016        PMID: 27622121      PMCID: PMC5010344          DOI: 10.1097/GOX.0000000000000861

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


× No keyword cloud information.

Sir:

Hemangiomas on the body surface are traditionally classified into strawberry, sponge, mixed, capillary, and racemosum hemangiomas. They were classified into 2 major categories, namely, hemangioma and vascular malformation, by Mulliken and Glowacki[1] in 1982. This was a milestone of progress in the classification of hemangioma. This classification was refined in 1996 and expanded in 2014 by the International Society for the Study of Vascular Anomalies [ISSVA].[2] Vascular tumors were further classified as benign, aggressive, and malignant. However, these classifications are not comprehensive and do not conform to the actual pathology of hemangiomas because hemangiomas are present not only on the body surface but also inside the body. This fact must be taken into consideration when studying the pathology of hemangiomas. In fact, most of the pathological formation of hemangiomas comprises other tissue components, such as fiber, fat, lymph, muscles, bones, nerves, and epithelioids.[3-5] These tissue components can occur in various forms, such as tumor or deformity, hyperplasia or nonhyperplasia, differentiated or undifferentiated, benign or malignant, and different tissue components occur in different proportions, thus forming a huge, complex hemangioma family. The mechanism of occurrence of hemangiomas may be related to pluripotent stem cell or mesenchymal stem cell developmental abnormalities in tumor locations. Therefore, the pathological model of hemangiomas should be composed of 3 parts, namely, vascular tumor, vascular malformation, and other tissue abnormalities, in order to be in concordance with the actual pathology and provide more guidance for the treatment of hemangiomas. Various treatment methods, especially the local drug injection treatment, affect not only the hemangioma and vascular malformations but also other tissues, thereby altering the quality of treatment. The classification released by ISSVA in 2014 is too complex for the general physicians to master; therefore, most types of hemangioma can be determined eventually only by histological examination. It is necessary to provide a simplified version of the model of hemangiomas at the same time, according to the incidence rate. Here is an attempt: The model of hemangioma Vascular tumor + vascular malformation + other tissue abnormalities Vascular tumor Common: infantile hemangioma; rare: invasive, malignant Malformations Common: venous, capillary, arteriovenous, lymphatic vessels; rare: mixed Tumor + malformation + other Common: mixed hemangioma; rare: various syndromes associated with vascular anomalies All common types account for more than 90% of all hemangiomas.

DISCLOSURE

The author has no financial interest to declare in relation to the content of this article. The Article Processing Charge was paid for by the author.
  5 in total

1.  ISSVA classification.

Authors:  Roshni Dasgupta; Steven J Fishman
Journal:  Semin Pediatr Surg       Date:  2014-06-19       Impact factor: 2.754

2.  Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.

Authors:  J B Mulliken; J Glowacki
Journal:  Plast Reconstr Surg       Date:  1982-03       Impact factor: 4.730

Review 3.  A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement.

Authors:  Samuel C Leong
Journal:  Laryngoscope       Date:  2013-04-02       Impact factor: 3.325

4.  Management of renal angiomyolipoma: analysis of 15 cases.

Authors:  O J Kessler; G Gillon; M Neuman; D Engelstein; H Winkler; J Baniel
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

5.  Immunohistochemical demonstration of substance P-containing nerve fibres in glomus tumours.

Authors:  S Kishimoto; H Nagatani; A Miyashita; K Kobayashi
Journal:  Br J Dermatol       Date:  1985-08       Impact factor: 9.302

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.